Humacyte Awarded $3.4 Million Contract Award from the U.S. Defense Department
October 2, 2017
6:59 pm
Humacyte, an innovator in biotechnology and regenerative medicine, announced today that the company has received a Broad Agency Announcement (BAA) contract award of $3.4 million from the U.S. Department of Defense (DoD). The funding will help support the addition of clinical sites for Humacyte’s Phase